Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
NOVEL EXENDIN AGONIST FORMULATIONS AND METHODS OF ADMINISTRATION THEREOF

No-Receipt date 2007-02060 - 18/05/2007
No-Filing date 20070800030 - 18/05/2007
No-Granting date 8000240 - 19/11/2007
No-EPO application date -
No-EPO granting date -
Gazette No-Publication date of application 10/2007 - 15/11/2007
Gazette No-Publication date of granted patent 11/2007 - 16/01/2008
Expiration date 20/11/2021
Kind of title Supplementary Protection Certificate for Medicinal Products
Legal status NOT VALID
Priorities -
Active Substance of Supplementary Certificates BYETTA-EXENATIDE

IPC Classification

Related Documents

Related Titles
TypeMaster titleRelated title
[SPC] 20050402607

Owners
CodeFirstnameSurnameAddressTownZIPCountry
960200 AMYLIN PHARMACEUTICALS, INC. 9360 TOWNE CENTRE DRIVE,SAN DIEGO, CA 92121, U.S.A. UNITED STATES OF AMERICA (USA)

Inventors
CodeFirstnameSurname
340007 KOLTERMAN, ORVILLE
340008 YOUNG, ANDREW
340009 L`ITALIEN, JAMES, J.

Representatives
CodeFirstnameSurnameAddressTownZip
2047CHRISTOSVARDIKOSMAVROMICHALI 3ATHINA (ATTIKIS)10679

Contact
CodeFirstnameSurnameAddressTownZipCountry
471CHRISTOSVARDIKOSMAVROMICHALI 3ATHINA (ATTIKIS)10679 GREECE

Owners History
Date Description Comments Data before modification Data after modification
19/09/2018 Αλλαγή Νομικής Μορφής (7g804) Α.Π.5110-Η.Θ.36176/13-9-18,ΔΝΥ1152, ΚΩΔ.ΠΛΗΡ.3458 145833 AMYLIN PHARMACEUTICALS, INC. 9373 Towne Centre Drive ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ San Diego, California 92121 960198 AMYLIN PHARMACEUTICALS, LLC 9360 Towne Centre Drive ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ San Diego, CA 92121
19/09/2018 Αλλαγή Έδρας (7g805) Α.Π.5112-Η.Θ.36177/13-9-18,ΔΝΥ1152,ΚΩΔ.ΠΛΗΡ.3458 960198 AMYLIN PHARMACEUTICALS, LLC 9360 Towne Centre Drive ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ San Diego, CA 92121 960199 AMYLIN PHARMACEUTICALS, LLC 1800 Concord Pike, Wilmington ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Delaware 19850, U.S.A.
19/09/2018 Μεταβίβαση (7g802) Α.Π.5111-Η.Θ.36175/13-9-18,ΔΝΥ1152, ΚΩΔ.ΠΛΗΡ.3458 960199 AMYLIN PHARMACEUTICALS, LLC 1800 Concord Pike, Wilmington ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Delaware 19850, U.S.A. 180087 AstraZeneca Pharmaeuticals LP 1800 Concord Pike, Wilmington ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Delaware, U.S.A.
19/09/2018 Αλλαγή Διεύθυνσης Δικαιούχου (7g800) Α.Π.5105-Η.Θ.36173/13-9-18,ΔΝΥ1152,ΚΩΔ.ΠΛΗΡ.3458 118720 AMYLIN PHARMACEUTICALS, INC. 9373 Towne Centre Drive, ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ San Diego, CA 92121, U.S.A. 960200 AMYLIN PHARMACEUTICALS, INC. 9360 Towne Centre Drive, ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ San Diego, CA 92121, U.S.A.

Title Instruments
DateOperationDescreption
10/11/2018 12:00:00 AMΓενική Παραίτηση (7g400) Με την αίτηση αριθμ. πρωτ. 5540/ΔΝΥ1317/03-10-2018 (ΗΘ 38595) η πληρεξούσια δικηγόρος κ. Μ.Αθανασιάδου υπέβαλε αίτηση ΠΑΡΑΙΤΗΣΗΣ.

Payments history
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015